What’s Happening With Cloud Software Company Salesforce’s Shares On Thursday?
Salesforce announced London as the site for its first AI center, following the company's $4 billion investment in new technologies in the UK.
BYD, A Tesla Rival, Maintains Second Spot In EV Battery Makers Market: Report
BYD Co., Ltd. maintains its position as the world's second-largest EV battery manufacturer from January to April.
J.M. Smucker’s Bottom-Line Shines In Q4 As Cost Management Pays Off: Details
J.M. Smucker shares rise as Q4 FY24 earnings report shows a gross profit surge of 15% Y/Y to $913.3 million and an expanded gross profit margin of 41.4%. Despite a 1.3% sales decline to $2.21 billion, adjusted EPS of $2.66 beat estimates.
AbbVie Announces Topline Results From Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine For High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer; PICCOLO Met Its Primary Endpoint With An ORR Of 51.9%; The Median DOR, A Key S…
PICCOLO trial met its primary endpoint of objective response rate (ORR)Data from the study will be presented at a future medical meetingNORTH CHICAGO, Ill., June 6, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced
Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September
The company also mentioned that it anticipates commercial delivery of the protein-based vaccine in the U.S. in September, pending authorization. The
Melt Pharmaceuticals Reports First Patient Dosed In Phase 3 Program Of Its MELT-300, For Needle- And Opioid-Free Sedation In Patients Undergoing Cataract Surgery; Topline Readout Expected In Q4 2024
Melt Pharmaceuticals, Inc. ("Melt"), a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced that the first patient has been dosed in its Phase 3 program evaluating
Motorsport Games Shares Surge After Regaining NASDAQ Compliance
The company is currently concentrating on revenue-driving initiatives.
Amazon Strengthens India Presence With MX Player Asset Acquisition: Report
Amazon.com is set to acquire assets from India's MX Player to strengthen its foothold in smaller cities. Valued under $100 million, this deal follows two years of negotiations with Times Internet.
Tonix Pharmaceuticals Presents Two Oral Presentations And One Poster Presentation Involving TNX-1500 At The American Transplant Congress 2024
TNX-1500 displays potential as a monotherapy or combination therapy to prevent rejection in organ transplantation in allograft and xenograft animal models Research Directed by Faculty of the Center for
Twist Bioscience Preclinical Data Detailing Discovery Of Antibody Targeting Emerging Checkpoint Inhibitor Published In The Journal PLOS ONE
TB206-001 shown to be a high-affinity, cross-reactive humanized antibody antagonist of A2AR with in vivo tumor suppressing activityTB206-001 available for out-licensingTwist Bioscience Corporation (NASDAQ:TWST), a